Cervical cancer prevention : New tools and old barriers (pages 2531–2542)
Isabel C. Scarinci, Francisco A.R. Garcia, Erin Kobetz, Edward E. Partridge, Heather M. Brandt, Maria C. Bell, Mark Dignan, Grace X. Ma, Jane L. Daye and Philip E. Castle
Version of Record online: 22 MAR 2010 | DOI: 10.1002/cncr.25065
Cervical cancer is the second most common female tumor worldwide, and its incidence is disproportionately high (>80%) in the developing world. In the United States, in which the Papanicolaou test has reduced the annual incidence to approximately 11,000 cervical cancers, >60% of cases are reported to occur in medically underserved populations as part of a complex of diseases linked to poverty, race/ethnicity, and/or health disparities.